Table 1.
Sample Tested | Country | Population Type | Prevalence | No. Positive/Total | Diagnostic Method | Breed | Ref. |
---|---|---|---|---|---|---|---|
Serum | Australia | Multicat environment | 44% | 59/135 | ELISA | Many | 185 |
Australia | Single cat household | 24% | 33/140 | ELISA | Many | 185 | |
Australia | Stray | 0% | 0/49 | ELISA | Not disclosed | 185 | |
Germany | Multicat environment | 69% | 29/42 | IFA | Mixed-breed | 68 | |
Italy | Multicat environment | 82% | 98/120 | ELISA | Not disclosed | 155 | |
Sweden | <5 cats in the environment | 29% | a/129 | IFA | Many | 186 | |
Sweden | ≥5 cats in the environment | 71% | a/24 | IFA | Many | 186 | |
Turkey | Multicat environment | 62% | 18/29 | VN | Not disclosed | 187 | |
Turkey | Single cat households | 4% | 3/71 | VN | Not disclosed | 187 | |
UK | Multicat environment | 28% | 28/100 | IFA | Many | 98 | |
UK | Single cat household | 16% | 14/88 | IFA | Many | 98 | |
UK | Multicat environment | 26% | 432/1654 | IFA | Many | 61 | |
UK | Multicat environment | 84% | 110/131 | IFA | Many | 188 | |
UK | Stray | 22% | 111/506 | IFA | Many | 189 | |
USA, Florida | Stray | 18% | 101/553 | IFA | Many | 64 | |
USA, California | Single cat households | 21% | 7/33 | IFA | Not disclosed | 60 | |
USA, California | Multicat environment | 87% | 94/108 | IFA | Not disclosed | 60 | |
Feces | Germany | Multicat environment | 38% | 16/42 | Nested RT-PCR | Mixed-breed | 68 |
Malaysia | Multicat environment | 96% | 23/24 | RT-PCR | Persian | 190 | |
Malaysia | Multicat environment | 70% | 14/20 | RT-PCR | Mixed-breed | 190 | |
Sweden | Multicat environment | 80% | 12/15 | Nested PCR | Persian | 191 | |
Sweden | Single cat household | 25% | 24/98 | Nested PCR | Many | 191 | |
Blood | Netherlands | Multicat environment | 5% | 23/424 | mRNA RT-PCR | Many | 170 |
Malaysia | Multicat environment | 15% | 6/40 | mRNA RT-PCR | Many | 169 | |
Turkey | Stray | 45% | 10/22 | mRNA RT-PCR | Many | 168 |
Abbreviations: ELISA, enzyme-linked immunosorbent assay; IFA, immunofluorescent antibody assay; mRNA, messenger RNA; RT-PCR, reverse transcriptase polymerase chain reaction; VN, virus neutralization assay.
Number of seropositives not provided.